COMP <GO>
PAHC vs GPCR // PIOTROSKI F-SCORE QUALITY
Phibro Animal Health Corporation (Class A) (NASDAQ) VS. Structure Therapeutics Inc. (NASDAQ) • 15-METRIC TALLY: PAHC 6
— GPCR 0
▲ PIOTROSKI F-SCORE QUALITY LEADER: PAHC
LAST: $38.88 (+0.05%) • MKT CAP: $1.58B
piotroski-score
8/9
LAST: $21.87 (-0.32%) • MKT CAP: $1.56B
piotroski-score
1/9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PAHC VS. GPCR)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | PAHC | GPCR | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 30.90% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 9.90% | -19.50% | +29.40 | PAHC | /roic <GO> |
| EV/EBITDA & P/E Valuation | 19.2x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 5.08% | -14.43% | +19.51 | PAHC | /fcf-yield <GO> |
| Operating Margin | 8.50% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | 3.70% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 27.40% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.23% | 0.00% | +1.23 | PAHC | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.87 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality ACTIVE | 8/9 | 1/9 | +7.00 | PAHC | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 56.8 | 27.1 | +29.70 | PAHC | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 27.5x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.58B | $1.56B | $13.2M | PAHC | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | PAHC REV | GPCR REV | PAHC GROSS % | GPCR GROSS % | PAHC FCF | GPCR FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.30B | $0 | 30.9% | — | $80.1M | -$225.8M |
| FY 2024 | $1.02B | $0 | 30.8% | — | $87.6M | -$117.9M |
| FY 2023 | $977.9M | $0 | — | — | $13.3M | -$79.5M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PAHC // BETA —
GPCR // BETA —